BFS
VRTX icon

BridgePort Financial Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

BridgePort Financial Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$551K Buy
1,233
+24
+2% +$11.2K 0.16% 118
2025
Q4 		$548K Buy
1,209
+218
+22% +$94K 0.15% 123
2025
Q3 		$388K Buy
991
+148
+18% +$61.9K 0.1% 152
2025
Q2 		$375K Buy
843
+50
+6% +$23K 0.12% 130
2025
Q1 		$384K Sell
793
-1
-0.1% -$466 0.17% 111
2024
Q4 		$377K Buy
+794
New +$368K 0.17% 111

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BridgePort Financial Solutions's VRTX Position: Q1 2026 in Review

BridgePort Financial Solutions increased its Vertex Pharmaceuticals (VRTX) stake by 2% in Q1 2026, buying an estimated $11.2K and bringing the position to 1,233 shares worth $551K. The position accounts for 0.16% of the portfolio, ranked #118.

BridgePort Financial Solutions first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • BridgePort Financial Solutions held 1,233 shares of Vertex Pharmaceuticals worth $551K as of Q1 2026.
  • BridgePort Financial Solutions bought 24 Vertex Pharmaceuticals shares in Q1 2026, an estimated $11.2K.
  • Vertex Pharmaceuticals made up 0.16% of BridgePort Financial Solutions's portfolio in Q1 2026, its #118 holding.
  • BridgePort Financial Solutions first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on BridgePort Financial Solutions's 13F filing for Q1 2026, filed 16 Apr 2026.